1. Home
  2. MRLN vs ANTX Comparison

MRLN vs ANTX Comparison

Compare MRLN & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merlin Inc. Common Stock

MRLN

Merlin Inc. Common Stock

HOLD

Current Price

$1.15

Market Cap

172.8M

Sector

Technology

ML Signal

HOLD

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$3.59

Market Cap

172.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRLN
ANTX
Founded
2018
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
172.8M
172.9M
IPO Year
2024
2022

Fundamental Metrics

Financial Performance
Metric
MRLN
ANTX
Price
$1.15
$3.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$7.92
★ $9.00
AVG Volume (30 Days)
★ 3.9M
315.3K
Earning Date
11-15-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 32.56
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$9.23
N/A
Revenue Next Year
$153.29
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.07
$1.00
52 Week High
$17.00
$7.19

Technical Indicators

Market Signals
Indicator
MRLN
ANTX
Relative Strength Index (RSI) 24.76 24.35
Support Level N/A $2.87
Resistance Level $3.45 $5.21
Average True Range (ATR) 0.14 0.43
MACD 0.00 -0.17
Stochastic Oscillator 8.52 9.40

Price Performance

Historical Comparison
MRLN
ANTX

About MRLN Merlin Inc. Common Stock

Merlin Inc develops software that fulfills the functions of a human pilot in self-flying aircraft to enable both reduced crew and unmanned flight. This technology is designed to be scalable and adaptable across different aircraft types for a growing range of aircraft platforms. The company's aircraft-agnostic, AI-powered software is purpose-built for military and civil programs, and is powering an expanding range of missions and aircraft, through hundreds of autonomous flights from test facilities across the globe. It operates as a single operating and reportable segment.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: